Nanosponges - A completely new nano-horizon: Pharmaceutical applications and recent advances

Drug Development and Industrial Pharmacy

Volumn 39, Issue 9, 2013, Pages 1263-1272

  Ahmed, Rana Z ^a   Patil, Gunjan ^a   Zaheer, Zahid ^a  

^a Y B CHAVAN COLLEGE OF PHARMACY   (India)

Author keywords

Cyclodextrin inclusion complex; Nanosponges; Protein and enzyme stabilization; Solubility enhancement; Tumor targeting

Indexed keywords

BENDROFLUMETHIAZIDE; BUDESONIDE; CAMPTOTHECIN; CROMOGLYCATE DISODIUM; CYCLODEXTRIN; DEXAMETHASONE; DOXORUBICIN; ECONAZOLE; FLURBIPROFEN; ITRACONAZOLE; NANOMATERIAL; NANOSPONGE; OLIGONUCLEOTIDE; RAFFINOSE; RESVERATROL; TREHALOSE; UNCLASSIFIED DRUG;

CELL VIABILITY; CHEMICAL STRUCTURE; CROSS LINKING; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG INDUSTRY; DRUG STABILITY; DRUG TARGETING; ENZYME IMMOBILIZATION; HUMAN; INFRARED SPECTROSCOPY; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NANOTECHNOLOGY; NUCLEAR MAGNETIC RESONANCE; OXYGEN SUPPLY; PATIENT COMPLIANCE; PROTEIN DEGRADATION; REVIEW; SCANNING ELECTRON MICROSCOPY; SUSTAINED DRUG RELEASE; SYNTHESIS; TOXICITY; WATER MANAGEMENT; X RAY POWDER DIFFRACTION;

ANIMALS; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG STABILITY; HUMANS; NANOSTRUCTURES; NANOTECHNOLOGY; PHARMACEUTICAL PREPARATIONS; SOLUBILITY; VISCOELASTIC SUBSTANCES;

EID: 84881140852     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2012.694610     Document Type: Review

References (38)

1. Patel M, Patel R, Shah D. Applications of cyclodextrin in drug delivery. Int J of Pharma World Research. 2010;1:1-16.
2. Weltrowski M, Morcellet M, Martel B. Cyclodextrin polymer and /or cyclodextrin derivatives with complexing properties and ion-exchange properties and method for the production thereof. 2003;US 6660804 B1.
3. Martin del valle EM. Cyclodextrin and their uses: a review. Process Biochem. 2004;39:1033-1046.
4. Szetjli J. Introduction and general overview of cyclodextrin chemistry. Chem Rev 1998;98:1743-1753.
5. Szejtli J. Past, present and future of cyclodextrin research. Pure Appl Chem 2004;76:1825-1845.
6. Salazar T. Nanosponges soak up contaminants and cut cleanup Costs dateline. Los Alamos, April issue 1998, Los Alamos, A Monthly publication of the public affairs office of Los Alamos national laboratory. 1998;1-3.
7. Baldvinsdóttir J, Ingvarsdóttir K, Kristmundsdóttir T, Loftsson T, Ólafsdóttir B. Preparation and physical evaluation of microcapsules of hydrophilic drug-cyclodextrin complexes. J Microencapsulation 1992;9:375-382.
8. Cavalli R, Trotta F, Tumiatti W. Cyclodextrin-based nanosponges for drug delivery. J Inclusion Phenom Macrocyclic Chem.2006;56:209-213.
9. Swaminathan S, Torne S, Trotta F, Vavia PR. Formulation of β-cyclodextrin based nanosponges of itraconazole. J Inclusion Phenom Macrocyclic Chem. 2007;57:89-94.
10. Swaminathan S, Pastero L, Serpe L, Trotta F, Vavia P, Aquilano D et al. (2010). Cyclodextrin-based nanosponges encapsulating camptothecin: physicochemical characterization, stability and cytotoxicity. Eur J Pharm Biopharm, 74:193-201.
11. Cavalli R, Ferruti P, Gerges I, Manfredi A, Ranucci E, Trotta F, Vavia PR et al. In vitro release modulation and conformational stabilization of a model protein using swellable polyamidoamine nanosponges of β-cyclodextrin. J Inclusion Phenom Macrocyclic Chem. 2010;68:183-191.
12. Aynie C, Chacun E, Fattal P, Vauthier H. Couvreur P, Sponge like alginate nanoparticles as a new potential system for the delivery of antisense oligonucleotides. Antisense Nucleic Acid Drug Dev.1999;9:301-312. (Pubitemid 29361064)
13. Ansari KA, Vavia PR, Trotta F, Cavalli R. (2011). Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study. AAPS PharmSciTech, 12:279-286.
14. Chu YH, Yamagishi M, Wang ZM, Kanoh H, Hirotsu T. (2007). Adsorption characteristics of nanoporous carbon-silica composites synthesized from graphite oxide by a mechanochemical intercalation method. J Colloid Interface Sci, 312:186-192. (Pubitemid 46935781)
15. Cavalli R, Trotta F, Tumiatti W. Ultra sound assisted synthesis of cyclodextrin-based nanosponges. 2006;WO 2006/002814.
16. Ahuja A, Ali J, Challa R, Khar RK. Cyclodextrins in drug delivery: an update review. AAPS PharmSciTech 2,6. Article 43 2005;E329-E357.
17. Nangia A. Organic nanoporous structure. Curr Opin Solid State Mater Sci 2001;5:115-122.
18. Alongi J, Frache A, Poskovic M, Trotta F. Novel flame retardants containing cyclodextrin nanosponges and phosphorus compounds to enhance EVA combustion properties. Polym Degrad Stab 2010;95:2093-2100.
19. Castiglione F, Ganazzoli F, Malpezzi L, Mele A, Raffaini G, Trotta F, et al. HR MAS NMR, powder XRD and Raman spectroscopy study of inclusion phenomena in β-CD nanosponges. J Inclusion Phenom Macrocyclic Chem. 2010;69:403-409.
20. Pathak K, Sharma R. Polymeric nanosponges as an alternative carrier for improved retention of econazole nitrate onto the skin through topical hydrogel formulation. Pharm Dev Technol 2011;16:367-376.
21. Du Y, John F, Lin B, Luo J, Wang X. Chitosan/organic rectorite nanocomposite films: Structure, characteristic and drug delivery behaviour. Carbohydr Polym 2007;69:41-49. (Pubitemid 46497424)
22. Ansari K, Bisazza A, Cavalli R, Giusetto P, Trotta F, Vavia P. Nanosponge formulations as oxygen delivery systems. Int J Pharm. 2010;402:254-257.
23. Ganazzoli F, Castiglione F, Mele A, Raffaini G. A molecular dynamics study of cyclodextrin nanosponge models. J Incl Phenom Macrocycl Chem. 2012; doi 10.1007/s10847-012-0126-8.
24. Castiglione V, Crupi D, Majolino D, Mele A, Panzeri W. et al. Vibrational dynamics and hydrogen bond properties of β-CD nanosponges: an FTIR-ATR, Raman and solid-state NMR spectroscopic study. J Incl Phenom Macrocycl Chem. 2012; doi 10.1007/s10847-012-0106-z
25. Allabashia R, Arkasb M, Hörmanna G, Tsiourvasb D. Removal of some organic pollutants in water employing ceramic membranes impregnated with cross-linked silylated dendritic and cyclodextrin polymers. Water Res. 2007;41:476-486.
26. Devecchi M, Martina K, Roggero C, Seglie L, Trotta F et al. The effects of 1-MCP in cyclodextrin-based nanosponges to improve the vase life of Dianthus caryophyllus cut flowers. Posthavest Biol Technol 2011;59:200-205.
27. Boscolo B, Ghibaudi E, Trotta F. High catalytic performances of Pseudomonas fluorescens lipase adsorbed on a new type of cyclodextrin-based nanosponges. J Mol Catal B: Enzym 2010;62:155-161.
28. Cavalli R, Trotta F. Characterization and application of new hyper-cross-linked cyclodextrin. Composite Interfaces. 2009;16:39-48.
29. Torne S, Darandale S, Vavia P, Trotta F, Cavalli R. (2012). Cyclodextrin-based nanosponges: effective nanocarrier for Tamoxifen delivery. Pharm Dev Technol, doi:10.3109/10837450.2011:649855.
30. Ansari K, Cavalli R, Torne SJ, Trotta F, Vavia P. Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded nanosponges. Drug Delivery. 2010;17:419-425.
31. Corrigan OI, Healy AH, Li J, Nolan LM, Tajber L. Particle engineering of materials for oral inhalation by dry powder inhalers II Sodium cromoglicate. Int J Pharm 2011;405:36-46.
32. Harth E, Diaz R. Nanosponge drug delivery system more effective than direct injection. Nanotechnology Now.[Online] 2010. Available at: http://www.vanderbilt.edu/exploration/stories/nanosponge.html. Accessed on 11 May 2012.
33. Corrigan OI, Healy AM, McDonald BF, Tajber L. Characterisation of excipient-free nanoporous microparticles (NPMPs) of bendroflumethiazide. Eur J Pharm Biopharm. 2008;69:1182-1186.
34. Barham AS, Corrigan OI, Lorraine MN, McDonald BF, Tajber L. et al. Excipient-free nanoporous microparticles of budesonide for pulmonary delivery. Eur J Pharm Sci 2009;37:593-602.
35. Corrigan OI, Healy AH, Li J, Nolan LM, Tajber L. Particle engineering of materials for oral inhalation by dry powder inhalers. I-Particles of sugar excipients (trehalose and raffinose) for protein delivery. Int J Pharm. 2010;405:23-35
36. Ansari K, Biasizzo M, Bordiga S, Cavalli R, Martina K, Trotta F. et al. Cyclodextrin nanosponges as effective gas carriers. J Inclusion Phenom Macrocyclic Chem 2011;71:189-194.
37. Holdich JJ, Malik DJ, Ramsden GL, Warwick IR, Webb RG. et al. Synthesis and characterization of size-selective nanoporous polymeric adsorbents for blood purification. Sep Purif Technol. 2009;66:578-585.
38. Foley HC, Tapan NS, Zydney AL. Development and characterization of nanoporous carbon membranes for protein ultrafiltration. J Membr Sci. 2007;295:40-49. (Pubitemid 46590583)